المؤلفون: Ku EJ; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea., Kim B; Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea., Han K; Department of Statistics and Actuarial Science, Soongsil University, Seoul, South Korea. hkd917@naver.com., Lee SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. hwanx2@catholic.ac.kr.; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, South Korea. hwanx2@catholic.ac.kr., Kwon HS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.

المصدر: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 03; Vol. 23 (1), pp. 329. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/adverse effects , Amputation, Surgical*/adverse effects , Peripheral Arterial Disease*/diagnosis , Peripheral Arterial Disease*/epidemiology , Peripheral Arterial Disease*/surgery , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/complications , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Risk Factors ; Treatment Outcome ; Republic of Korea/epidemiology ; Retrospective Studies ; Rhabdomyolysis/diagnosis ; Rhabdomyolysis/epidemiology ; Rhabdomyolysis/chemically induced ; Databases, Factual ; Time Factors ; Acute Kidney Injury/prevention & control ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/diagnosis ; Adult ; Diabetic Angiopathies/diagnosis ; Diabetic Angiopathies/prevention & control ; Diabetic Angiopathies/epidemiology

المؤلفون: Fayyaz S; Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan., Islam M; Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan., Ahmed A; Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan., Saeed H; Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan.

المصدر: Cell biochemistry and function [Cell Biochem Funct] 2024 Sep; Vol. 42 (7), pp. e4124.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8305874 Publication Model: Print Cited Medium: Internet ISSN: 1099-0844 (Electronic) Linking ISSN: 02636484 NLM ISO Abbreviation: Cell Biochem Funct Subsets: MEDLINE

مواضيع طبية MeSH: Ficus*/chemistry , Seeds*/chemistry , Plant Extracts*/chemistry , Plant Extracts*/pharmacology , Molecular Docking Simulation* , Hypolipidemic Agents*/pharmacology , Hypolipidemic Agents*/chemistry , Hypolipidemic Agents*/isolation & purification, Lipase/antagonists & inhibitors ; Lipase/metabolism ; Humans ; Hyperlipidemias/drug therapy

المؤلفون: Saleem B; Section of Pharmaceutical Chemistry, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan., Islam M; Section of Pharmaceutical Chemistry, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan., Ahmed A; Section of Phamarcognosy, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan., Saeed H; Section of Pharmaceutics, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan., Imtiaz F; Section of Pharmaceutical Chemistry, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan., Muzaffar S; Section of Pharmaceutical Chemistry, Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan.

المصدر: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2024 Sep; Vol. 42 (15), pp. 8009-8023. Date of Electronic Publication: 2023 Aug 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-0254 (Electronic) Linking ISSN: 07391102 NLM ISO Abbreviation: J Biomol Struct Dyn Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Docking Simulation* , Hypolipidemic Agents*/chemistry , Hypolipidemic Agents*/pharmacology , Hypolipidemic Agents*/isolation & purification , Molecular Dynamics Simulation* , Lipase*/antagonists & inhibitors , Lipase*/metabolism , Lipase*/chemistry , Plant Extracts*/chemistry , Plant Extracts*/pharmacology, Biological Assay ; Computer Simulation ; Phytochemicals/pharmacology ; Phytochemicals/chemistry ; Phytochemicals/isolation & purification

المؤلفون: Wu X; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China., Li W; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China., Li S; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China., Zhu S; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China., Pan F; Wenzhou Xingbei Seaweed Food Co., Ltd., China., Gu Q; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China., Song D; Key Laboratory for Food Microbial Technology of Zhejiang Province, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou 310018, Zhejiang, China. Electronic address: dfsong@zjsu.edu.cn.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 Sep; Vol. 276 (Pt 1), pp. 133771. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: Zebrafish* , Sargassum*/chemistry , Polysaccharides*/pharmacology , Polysaccharides*/chemistry , Hypolipidemic Agents*/pharmacology , Hypolipidemic Agents*/chemistry , Diet, High-Fat* , Lipid Metabolism*/drug effects, Animals ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Lipoprotein Lipase/metabolism ; Triglycerides/blood ; Triglycerides/metabolism ; Hyperlipidemias/drug therapy ; Hyperlipidemias/metabolism ; Cholesterol/blood ; Cholesterol/metabolism ; Lipase/metabolism ; Edible Seaweeds

SCR Organism: Sargassum fusiforme

المؤلفون: Shehata TM; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf, Al-Ahsa, 36362, Saudi Arabia.; Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt., Aldhubiab B; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Alhofuf, Al-Ahsa, 36362, Saudi Arabia., Elsewedy HS; Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 11597, Saudi Arabia.

المصدر: International journal of nanomedicine [Int J Nanomedicine] 2024 Aug 05; Vol. 19, pp. 7945-7961. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/pharmacokinetics , Rosuvastatin Calcium*/chemistry , Rosuvastatin Calcium*/pharmacology , Rosuvastatin Calcium*/administration & dosage , Coconut Oil*/chemistry , Coconut Oil*/pharmacology , Hypolipidemic Agents*/chemistry , Hypolipidemic Agents*/pharmacology , Hypolipidemic Agents*/pharmacokinetics , Hypolipidemic Agents*/administration & dosage , Drug Carriers*/chemistry , Particle Size* , Nanostructures*/chemistry, Animals ; Male ; Rats ; Lipids/chemistry ; Lipids/blood ; Rats, Wistar ; Drug Liberation ; Biological Availability ; Administration, Oral

المؤلفون: Silva PS; Department of Ophthalmology, Harvard Medical School, Boston.; Beetham Eye Institute, Joslin Diabetes Center, Boston., Aiello LP; Department of Ophthalmology, Harvard Medical School, Boston.; Beetham Eye Institute, Joslin Diabetes Center, Boston.

المصدر: NEJM evidence [NEJM Evid] 2024 Aug; Vol. 3 (8), pp. EVIDe2400205. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: News; Editorial; Comment

بيانات الدورية: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/pharmacology , Diabetic Retinopathy*/drug therapy , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/pharmacology , Disease Progression*, Humans

المؤلفون: Tang H; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Guo KX; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Huang KE; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Li YF; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Chen W; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Wei HY; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Yu XQ; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China., Ke XH; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

المصدر: Biomedical chromatography : BMC [Biomed Chromatogr] 2024 Aug; Vol. 38 (8), pp. e5922. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0801 (Electronic) Linking ISSN: 02693879 NLM ISO Abbreviation: Biomed Chromatogr Subsets: MEDLINE

مواضيع طبية MeSH: Drugs, Chinese Herbal* , Metabolomics*/methods , Hypolipidemic Agents*/blood , Hypolipidemic Agents*/pharmacokinetics , Hypolipidemic Agents*/chemistry , Hyperlipidemias*/drug therapy , Hyperlipidemias*/blood, Chromatography, High Pressure Liquid/methods ; Animals ; Male ; Biomarkers/blood ; Rats ; Metabolome/drug effects ; Rats, Sprague-Dawley ; Mass Spectrometry/methods

المؤلفون: Preiss D; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Logue J; Faculty of Health and Medicine, University of Lancaster, Lancaster, United Kingdom., Sammons E; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Zayed M; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Emberson J; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Wade R; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Wallendszus K; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Stevens W; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Cretney R; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Harding S; Department of Eye and Vision Science, University of Liverpool and St. Paul's Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom., Leese G; Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom., Currie G; School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Armitage J; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

المصدر: NEJM evidence [NEJM Evid] 2024 Aug; Vol. 3 (8), pp. EVIDoa2400179. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

مواضيع طبية MeSH: Fenofibrate*/therapeutic use , Fenofibrate*/pharmacology , Diabetic Retinopathy*/drug therapy , Disease Progression* , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Double-Blind Method

المؤلفون: Highton P; Diabetes Research Centre, University of Leicester, Leicester General Hospital, United Kingdom (P.H., K.K.).; National Institute for Health and Care Research Applied Research Collaboration East Midlands, Leicester, United Kingdom (P.H., K.K.)., Khunti K; Diabetes Research Centre, University of Leicester, Leicester General Hospital, United Kingdom (P.H., K.K.).; National Institute for Health and Care Research Applied Research Collaboration East Midlands, Leicester, United Kingdom (P.H., K.K.).

المصدر: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2024 Aug; Vol. 17 (8), pp. e011189. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Letter

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-7705 (Electronic) Linking ISSN: 19417713 NLM ISO Abbreviation: Circ Cardiovasc Qual Outcomes Subsets: MEDLINE

مواضيع طبية MeSH: Hyperlipidemias*/drug therapy , Hyperlipidemias*/diagnosis , Hyperlipidemias*/therapy , Randomized Controlled Trials as Topic* , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/adverse effects, Humans ; Treatment Outcome ; Biomarkers/blood ; Lipids/blood ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects

المؤلفون: Modica R; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80131, Naples, Italy. roberta.modica@unina.it., La Salvia A; National Center for Drug Research and Evaluation, National Institute of Health (ISS), 00161, Rome, Italy., Liccardi A; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80131, Naples, Italy., Cozzolino A; Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy., Di Sarno A; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80131, Naples, Italy., Russo F; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, 00189, Rome, Italy., Colao A; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80131, Naples, Italy.; UNESCO Chair, Education for Health and Sustainable Development, Federico II University, 80131, Naples, Italy., Faggiano A; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, 00189, Rome, Italy.

مؤلفون مشاركون: NIKE group

المصدر: Endocrine [Endocrine] 2024 Aug; Vol. 85 (2), pp. 520-531. Date of Electronic Publication: 2024 Mar 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE

مواضيع طبية MeSH: Dyslipidemias*/drug therapy , Neuroendocrine Tumors*/drug therapy , Hypolipidemic Agents*/therapeutic use , Hypolipidemic Agents*/pharmacology, Humans ; Lipid Metabolism/drug effects